| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| AL_RIC - Bandi da altri enti di ricerca |
Validazione di due nuovi trattamenti per la sindrome di Rett: focus sui difetti respiratori della malattia
|
|
Ongoing | 2022 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Fluoxetine reveres cognitive defects in a mouse model of AT: a preclinical study to elucidate the precise mechanism of action
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
The interplay between HPCAL4 and MeCP2: identification and characterization of a novel putative target for Rett syndrome therapy
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Metastasis AS Mechanodisease - 4° anno
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Exploiting innate lymphoid cells to predict clinical progression and response to therapy in myelodysplastic syndromes (1° anno)
|
|
Ongoing | 2022 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Dissecting the molecular mechanism linking GCase-dependent lysosomal impairment with Parkinson’s disease
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Targeting Drp1 activation and mitochondrial Fission tO Curtail muscle wasting during Duchenne MUscular DyStrophy progression (FOCUS)
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
The link between metabolism and epigenetics in myocardial diseases
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
Multimodal Innovative THeranostic nanoSystem
|
|
Ongoing | 2022 |
